FMO5 and chronic kidney disease: Moreover, significant decrease in NADPH oxidase protein level was observed in both CKD/Sham and Sham groups compared to CKD or CKD/CKD groups indicating that there was no sign of oxidative damage in CKD/Sham group (Figure 9F).